We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
LEF1
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • LEF1
PROTEIN SUMMARY GENE INFORMATION RNA DATA ANTIBODY DATA
GENERAL INFORMATIONi

General description of the gene and the encoded protein(s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project.

Gene namei

Official gene symbol, which is typically a short form of the gene name, according to HGNC.

LEF1
Synonyms TCF10, TCF1ALPHA, TCF7L3
Gene descriptioni

Full gene name according to HGNC.

Lymphoid enhancer binding factor 1
Protein classi

Assigned HPA protein class(es) for the encoded protein(s).

Cancer-related genes
Plasma proteins
Transcription factors
Predicted locationi

All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions.

  • Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached.

  • Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s).

The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.

Intracellular
Protein evidence Evidence at protein level (all genes)
GENE INFORMATIONi

Gene information from Ensembl and Entrez, as well as links to available gene identifiers are displayed here. Information was retrieved from Ensembl if not indicated otherwise.

Chromosome 4
Cytoband q25
Chromosome location (bp) 108047545 - 108168956
Number of transcriptsi

Number of protein-coding transcripts from the gene as defined by Ensembl.

6
Ensembl ENSG00000138795 (version 109)
Entrez gene 51176
HGNC HGNC:6551
UniProt Q9UJU2 (UniProt - Evidence at protein level)
neXtProt NX_Q9UJU2
GeneCards LEF1
Antibodypedia LEF1 antibodies


PROTEIN FUNCTION
Protein function (UniProt)i

Useful information about the protein provided by UniProt.

Transcription factor that binds DNA in a sequence-specific manner 1. Participates in the Wnt signaling pathway (By similarity). Activates transcription of target genes in the presence of CTNNB1 and EP300 (By similarity). PIAG antagonizes both Wnt-dependent and Wnt-independent activation by LEF1 (By similarity). TLE1, TLE2, TLE3 and TLE4 repress transactivation mediated by LEF1 and CTNNB1 2. Regulates T-cell receptor alpha enhancer function 3. Required for IL17A expressing gamma-delta T-cell maturation and development, via binding to regulator loci of BLK to modulate expression (By similarity). Acts as a positive regulator of odontoblast differentiation during mesenchymal tooth germ formation, expression is repressed during the bell stage by MSX1-mediated inhibition of CTNNB1 signaling (By similarity). May play a role in hair cell differentiation and follicle morphogenesis (By similarity).... show less
Molecular function (UniProt)i

Keywords assigned by UniProt to proteins due to their particular molecular function.

Activator, DNA-binding
Biological process (UniProt)i

Keywords assigned by UniProt to proteins because they are involved in a particular biological process.

Transcription, Transcription regulation, Wnt signaling pathway
Gene summary (Entrez)i

Useful information about the gene from Entrez

This gene encodes a transcription factor belonging to a family of proteins that share homology with the high mobility group protein-1. The protein encoded by this gene can bind to a functionally important site in the T-cell receptor-alpha enhancer, thereby conferring maximal enhancer activity. This transcription factor is involved in the Wnt signaling pathway, and it may function in hair cell differentiation and follicle morphogenesis. Mutations in this gene have been found in somatic sebaceous tumors. This gene has also been linked to other cancers, including androgen-independent prostate cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]... show less
PROTEIN INFORMATIONi

The protein information section displays alternative protein-coding transcripts (splice variants) encoded by this gene according to the Ensembl database.

The Splice variant identifier links to the Ensembl website protein summary for the selected splice variant. The data in the Swissprot and TrEMBL columns links to corresponding pages in the UniProt database.

The protein classes assigned to this protein are shown if expanding the data in the protein class column. Parent protein classes are in bold font and subclasses are listed under the parent class.

The length of the protein (amino acid residues according to Ensembl), molecular mass (kDalton), predicted signal peptide and number of predicted transmembrane region(s) according to in-house majority decision methods based on sets of predictors are also reported.
Splice variant SwissProt TrEMBL Protein class Gene ontology Length & mass Signal peptide
(predicted)
Transmembrane regions
(predicted)
LEF1-201
ENSP00000265165
ENST00000265165
Q9UJU2
[Direct mapping] Lymphoid enhancer-binding factor 1
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Other all-alpha-helical DNA-binding domains
Cancer-related genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000976 [transcription cis-regulatory region binding]
GO:0000977 [RNA polymerase II transcription regulatory region sequence-specific DNA binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0000987 [cis-regulatory region sequence-specific DNA binding]
GO:0001222 [transcription corepressor binding]
GO:0001227 [DNA-binding transcription repressor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0001569 [branching involved in blood vessel morphogenesis]
GO:0001649 [osteoblast differentiation]
GO:0001756 [somitogenesis]
GO:0001837 [epithelial to mesenchymal transition]
GO:0001944 [vasculature development]
GO:0002040 [sprouting angiogenesis]
GO:0003677 [DNA binding]
GO:0003682 [chromatin binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005667 [transcription regulator complex]
GO:0005737 [cytoplasm]
GO:0006355 [regulation of DNA-templated transcription]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0006366 [transcription by RNA polymerase II]
GO:0008013 [beta-catenin binding]
GO:0008301 [DNA binding, bending]
GO:0010628 [positive regulation of gene expression]
GO:0010718 [positive regulation of epithelial to mesenchymal transition]
GO:0016055 [Wnt signaling pathway]
GO:0021542 [dentate gyrus development]
GO:0021766 [hippocampus development]
GO:0021861 [forebrain radial glial cell differentiation]
GO:0021873 [forebrain neuroblast division]
GO:0021943 [formation of radial glial scaffolds]
GO:0022407 [regulation of cell-cell adhesion]
GO:0030111 [regulation of Wnt signaling pathway]
GO:0030177 [positive regulation of Wnt signaling pathway]
GO:0030223 [neutrophil differentiation]
GO:0030326 [embryonic limb morphogenesis]
GO:0030331 [nuclear estrogen receptor binding]
GO:0030335 [positive regulation of cell migration]
GO:0030509 [BMP signaling pathway]
GO:0030854 [positive regulation of granulocyte differentiation]
GO:0030879 [mammary gland development]
GO:0032696 [negative regulation of interleukin-13 production]
GO:0032713 [negative regulation of interleukin-4 production]
GO:0032714 [negative regulation of interleukin-5 production]
GO:0032993 [protein-DNA complex]
GO:0033153 [T cell receptor V(D)J recombination]
GO:0042100 [B cell proliferation]
GO:0042393 [histone binding]
GO:0042475 [odontogenesis of dentin-containing tooth]
GO:0042826 [histone deacetylase binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0043392 [negative regulation of DNA binding]
GO:0043565 [sequence-specific DNA binding]
GO:0043586 [tongue development]
GO:0043923 [positive regulation by host of viral transcription]
GO:0045063 [T-helper 1 cell differentiation]
GO:0045295 [gamma-catenin binding]
GO:0045588 [positive regulation of gamma-delta T cell differentiation]
GO:0045597 [positive regulation of cell differentiation]
GO:0045843 [negative regulation of striated muscle tissue development]
GO:0045892 [negative regulation of DNA-templated transcription]
GO:0045893 [positive regulation of DNA-templated transcription]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046632 [alpha-beta T cell differentiation]
GO:0048341 [paraxial mesoderm formation]
GO:0048468 [cell development]
GO:0050767 [regulation of neurogenesis]
GO:0050909 [sensory perception of taste]
GO:0060033 [anatomical structure regression]
GO:0060070 [canonical Wnt signaling pathway]
GO:0060325 [face morphogenesis]
GO:0060326 [cell chemotaxis]
GO:0060561 [apoptotic process involved in morphogenesis]
GO:0060710 [chorio-allantoic fusion]
GO:0061153 [trachea gland development]
GO:0062009 [secondary palate development]
GO:0070016 [armadillo repeat domain binding]
GO:0070742 [C2H2 zinc finger domain binding]
GO:0071168 [protein localization to chromatin]
GO:0071345 [cellular response to cytokine stimulus]
GO:0071353 [cellular response to interleukin-4]
GO:0071864 [positive regulation of cell proliferation in bone marrow]
GO:0071866 [negative regulation of apoptotic process in bone marrow cell]
GO:0090575 [RNA polymerase II transcription regulator complex]
GO:0097043 [histone H3-K56 acetylation]
GO:0140416 [transcription regulator inhibitor activity]
GO:1902262 [apoptotic process involved in blood vessel morphogenesis]
GO:1902732 [positive regulation of chondrocyte proliferation]
GO:1904019 [epithelial cell apoptotic process]
GO:1990837 [sequence-specific double-stranded DNA binding]
GO:1990907 [beta-catenin-TCF complex]
Show all
399 aa
44.2 kDa
No 0
LEF1-202
ENSP00000369284
ENST00000379951
Q9UJU2
[Direct mapping] Lymphoid enhancer-binding factor 1
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Other all-alpha-helical DNA-binding domains
Cancer-related genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000977 [RNA polymerase II transcription regulatory region sequence-specific DNA binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0001222 [transcription corepressor binding]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0001649 [osteoblast differentiation]
GO:0001837 [epithelial to mesenchymal transition]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005667 [transcription regulator complex]
GO:0005737 [cytoplasm]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0008013 [beta-catenin binding]
GO:0008301 [DNA binding, bending]
GO:0010628 [positive regulation of gene expression]
GO:0010718 [positive regulation of epithelial to mesenchymal transition]
GO:0016055 [Wnt signaling pathway]
GO:0030223 [neutrophil differentiation]
GO:0030331 [nuclear estrogen receptor binding]
GO:0030335 [positive regulation of cell migration]
GO:0030854 [positive regulation of granulocyte differentiation]
GO:0032696 [negative regulation of interleukin-13 production]
GO:0032713 [negative regulation of interleukin-4 production]
GO:0032714 [negative regulation of interleukin-5 production]
GO:0032993 [protein-DNA complex]
GO:0042393 [histone binding]
GO:0042826 [histone deacetylase binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0043392 [negative regulation of DNA binding]
GO:0043565 [sequence-specific DNA binding]
GO:0043923 [positive regulation by host of viral transcription]
GO:0045063 [T-helper 1 cell differentiation]
GO:0045295 [gamma-catenin binding]
GO:0045588 [positive regulation of gamma-delta T cell differentiation]
GO:0045597 [positive regulation of cell differentiation]
GO:0045892 [negative regulation of DNA-templated transcription]
GO:0045893 [positive regulation of DNA-templated transcription]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0050767 [regulation of neurogenesis]
GO:0060070 [canonical Wnt signaling pathway]
GO:0060326 [cell chemotaxis]
GO:0062009 [secondary palate development]
GO:0070016 [armadillo repeat domain binding]
GO:0070742 [C2H2 zinc finger domain binding]
GO:0071168 [protein localization to chromatin]
GO:0071345 [cellular response to cytokine stimulus]
GO:0071353 [cellular response to interleukin-4]
GO:0071864 [positive regulation of cell proliferation in bone marrow]
GO:0071866 [negative regulation of apoptotic process in bone marrow cell]
GO:0140416 [transcription regulator inhibitor activity]
GO:1990837 [sequence-specific double-stranded DNA binding]
GO:1990907 [beta-catenin-TCF complex]
Show all
386 aa
42.7 kDa
No 0
LEF1-203
ENSP00000406176
ENST00000438313
Q9UJU2
[Direct mapping] Lymphoid enhancer-binding factor 1
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Other all-alpha-helical DNA-binding domains
Cancer-related genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000977 [RNA polymerase II transcription regulatory region sequence-specific DNA binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0001222 [transcription corepressor binding]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0001649 [osteoblast differentiation]
GO:0001837 [epithelial to mesenchymal transition]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005667 [transcription regulator complex]
GO:0005737 [cytoplasm]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0008013 [beta-catenin binding]
GO:0008301 [DNA binding, bending]
GO:0010628 [positive regulation of gene expression]
GO:0010718 [positive regulation of epithelial to mesenchymal transition]
GO:0016055 [Wnt signaling pathway]
GO:0030223 [neutrophil differentiation]
GO:0030331 [nuclear estrogen receptor binding]
GO:0030335 [positive regulation of cell migration]
GO:0030854 [positive regulation of granulocyte differentiation]
GO:0032696 [negative regulation of interleukin-13 production]
GO:0032713 [negative regulation of interleukin-4 production]
GO:0032714 [negative regulation of interleukin-5 production]
GO:0032993 [protein-DNA complex]
GO:0042393 [histone binding]
GO:0042826 [histone deacetylase binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0043392 [negative regulation of DNA binding]
GO:0043565 [sequence-specific DNA binding]
GO:0043923 [positive regulation by host of viral transcription]
GO:0045063 [T-helper 1 cell differentiation]
GO:0045295 [gamma-catenin binding]
GO:0045588 [positive regulation of gamma-delta T cell differentiation]
GO:0045597 [positive regulation of cell differentiation]
GO:0045892 [negative regulation of DNA-templated transcription]
GO:0045893 [positive regulation of DNA-templated transcription]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0050767 [regulation of neurogenesis]
GO:0060070 [canonical Wnt signaling pathway]
GO:0060326 [cell chemotaxis]
GO:0062009 [secondary palate development]
GO:0070016 [armadillo repeat domain binding]
GO:0070742 [C2H2 zinc finger domain binding]
GO:0071168 [protein localization to chromatin]
GO:0071345 [cellular response to cytokine stimulus]
GO:0071353 [cellular response to interleukin-4]
GO:0071864 [positive regulation of cell proliferation in bone marrow]
GO:0071866 [negative regulation of apoptotic process in bone marrow cell]
GO:0090068 [positive regulation of cell cycle process]
GO:0140416 [transcription regulator inhibitor activity]
GO:1990837 [sequence-specific double-stranded DNA binding]
GO:1990907 [beta-catenin-TCF complex]
Show all
371 aa
41.2 kDa
No 0
LEF1-216
ENSP00000422840
ENST00000510624
Q9UJU2
[Direct mapping] Lymphoid enhancer-binding factor 1
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Other all-alpha-helical DNA-binding domains
Cancer-related genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000977 [RNA polymerase II transcription regulatory region sequence-specific DNA binding]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0001222 [transcription corepressor binding]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0001649 [osteoblast differentiation]
GO:0001837 [epithelial to mesenchymal transition]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005667 [transcription regulator complex]
GO:0005737 [cytoplasm]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0008013 [beta-catenin binding]
GO:0008301 [DNA binding, bending]
GO:0010628 [positive regulation of gene expression]
GO:0010718 [positive regulation of epithelial to mesenchymal transition]
GO:0016055 [Wnt signaling pathway]
GO:0030223 [neutrophil differentiation]
GO:0030331 [nuclear estrogen receptor binding]
GO:0030335 [positive regulation of cell migration]
GO:0030854 [positive regulation of granulocyte differentiation]
GO:0032696 [negative regulation of interleukin-13 production]
GO:0032713 [negative regulation of interleukin-4 production]
GO:0032714 [negative regulation of interleukin-5 production]
GO:0032993 [protein-DNA complex]
GO:0042393 [histone binding]
GO:0042826 [histone deacetylase binding]
GO:0043066 [negative regulation of apoptotic process]
GO:0043392 [negative regulation of DNA binding]
GO:0043565 [sequence-specific DNA binding]
GO:0043923 [positive regulation by host of viral transcription]
GO:0045063 [T-helper 1 cell differentiation]
GO:0045295 [gamma-catenin binding]
GO:0045588 [positive regulation of gamma-delta T cell differentiation]
GO:0045597 [positive regulation of cell differentiation]
GO:0045892 [negative regulation of DNA-templated transcription]
GO:0045893 [positive regulation of DNA-templated transcription]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0050767 [regulation of neurogenesis]
GO:0060070 [canonical Wnt signaling pathway]
GO:0060326 [cell chemotaxis]
GO:0062009 [secondary palate development]
GO:0070016 [armadillo repeat domain binding]
GO:0070742 [C2H2 zinc finger domain binding]
GO:0071168 [protein localization to chromatin]
GO:0071345 [cellular response to cytokine stimulus]
GO:0071353 [cellular response to interleukin-4]
GO:0071864 [positive regulation of cell proliferation in bone marrow]
GO:0071866 [negative regulation of apoptotic process in bone marrow cell]
GO:0140416 [transcription regulator inhibitor activity]
GO:1990837 [sequence-specific double-stranded DNA binding]
GO:1990907 [beta-catenin-TCF complex]
Show all
303 aa
34.1 kDa
No 0
LEF1-218
ENSP00000427365
ENST00000512172
D6RIV1
[Direct mapping] Lymphoid enhancer-binding factor 1
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0008013 [beta-catenin binding]
GO:0016055 [Wnt signaling pathway]
Show all
145 aa
15.8 kDa
No 0
LEF1-221
ENSP00000422801
ENST00000515500
D6RAB1
[Direct mapping] Lymphoid enhancer-binding factor 1
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Nonsense Mutations
   COSMIC Missense Mutations
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0008013 [beta-catenin binding]
GO:0016055 [Wnt signaling pathway]
Show all
173 aa
18.8 kDa
No 0

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org